[Skip to Content]
[Skip to Content Landing]
Article
January 1955

LIPOLIQUID IN TREATMENT OF HEMORRHAGIC DIABETIC RETINOPATHY

Author Affiliations

Chicago
From the Department of Ophthalmology of the Mount Sinai Hospital and the Chicago Medical School.

AMA Arch Ophthalmol. 1955;53(1):93. doi:10.1001/archopht.1955.00930010095009

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

MANY DRUGS have been used in an attempt to abort the vascular complications of diabetes mellitus. To date none has proved effective. Recently the liver has been implicated as possibly playing a role in these vascular complications. A tendency toward fatty infiltration of the liver has been noted in diabetes and arteriosclerosis. This fatty infiltration is believed to impair liver function and thereby predispose, in some as yet unknown manner, to increased vascular disease. By reducing fatty infiltration by the use of lipotropic substances, and thereby improving liver function, it is hoped that the vascular disease will be arrested. The lipoliquid used in this study contains choline, the most effective lipotropic agent known, inositol, and vitamin B12, believed to be catalysts in the formation of the mobile cholinebased phospholipids.

It is the purpose of this report to note the effect of Lipoliquid used in the treatment of 50 consecutive

First Page Preview View Large
First page PDF preview
First page PDF preview
×